Elevance Health (ELV) shares took a hit following UnitedHealth Group’s third-quarter earnings report, which highlighted intensifying competition in the healthcare insurance sector. UnitedHealth’s strong financial performance and market share gains, particularly in the Optum division, raise concerns about Elevance’s ability to maintain its own growth trajectory. Rising medical costs and regulatory scrutiny of pharmacy benefit managers (PBMs) further complicate the outlook for both companies.